By Connor Hart

Boeing lost roughly $4 billion in the most recent quarter, dragged down by strikes, mounting losses in troubled U.S. government projects and costs tied to job cuts rolled out at the end of last year. The jet maker said it expects to report revenue of $15.2 billion for the latest quarter, compared with Wall Street's forecast of $16.6 billion. Its operations had negative cash flow of $3.5 billion in the December quarter, coming in slightly better than investors had feared. Shares fall 2%, to $175.02, in after-hours trading.

Texas Instruments reported lower profit and revenue in the fourth quarter, while its first-quarter outlook missed expectations. The chipmaker reported a profit of $1.21 billion on revenue of $4.01 billion, down from a profit of $1.37 billion on revenue of $4.08 billion a year earlier. For the current quarter, it guided for per-share earnings between 94 cents and $1.16, the midpoint of which is below the $1.17 a share that analysts polled by FactSet are expecting. Shares fall 4.3%, to $191.93, in postmarket trading.

Allurion Technologies said it would initiate a clinical study on the combination of certain weight-loss drugs and its Allurion program with the goal of improving muscle mass. Chief Executive Shantanu Gaur said the goal of the study would be to prove that combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy would lead to patients losing significant weight while increasing muscle mass and improving overall body composition. Shares rise 67%, to $6.17, in after-hours trading.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

January 23, 2025 18:56 ET (23:56 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.